CG
UTHR icon

Clinton Group’s United Therapeutics UTHR Stock Holding History

Clinton Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-7,200
Closed -$815K – 385
2018
Q2 		$815K Buy
+7,200
New +$791K 0.13% 220
2017
Q4 		– Sell
-6,553
Closed -$768K – 508
2017
Q3 		$768K Sell
6,553
-2,809
-30% -$359K 0.08% 246
2017
Q2 		$1.22M Buy
9,362
+6,681
+249% +$833K 0.12% 257
2017
Q1 		$363K Buy
+2,681
New +$406K 0.02% 712
2016
Q4 		– Sell
-9,028
Closed -$1.07M – 1024
2016
Q3 		$1.07M Sell
9,028
-18,378
-67% -$2.21M 0.05% 450
2016
Q2 		$2.9M Sell
27,406
-32,307
-54% -$3.6M 0.13% 227
2016
Q1 		$6.65M Buy
59,713
+58,383
+4,390% +$7.39M 0.4% 46
2015
Q4 		$208K Sell
1,330
-5,191
-80% -$756K 0.02% 708
2015
Q3 		$856K Buy
6,521
+1,832
+39% +$294K 0.08% 343
2015
Q2 		$816K Buy
4,689
+1,256
+37% +$226K 0.11% 282
2015
Q1 		$592K Buy
3,433
+65
+2% +$9.91K 0.15% 206
2014
Q4 		$436K Buy
+3,368
New +$434K 0.14% 264
2014
Q3 		– Sell
-4,660
Closed -$412K – 486
2014
Q2 		$412K Sell
4,660
-3,366
-42% -$324K 0.2% 181
2014
Q1 		$755K Buy
+8,026
New +$821K 0.28% 80
2013
Q4 		– Sell
-3,522
Closed -$278K – 415
2013
Q3 		$278K Sell
3,522
-9,908
-74% -$724K 0.08% 260
2013
Q2 		$884K Buy
+13,430
New +$865K 0.29% 49

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Clinton Group's UTHR Position: Q3 2018 in Review

Clinton Group sold out of United Therapeutics (UTHR) in Q3 2018, closing a stake of 7,200 shares — an estimated $815K sold.

Clinton Group first reported a position in UTHR in Q2 2013 and held it in 16 quarters. The position peaked at $6.65M in Q1 2016. 367 funds tracked by Wall St. Rank hold UTHR as of Q3 2018.

  • Clinton Group reported no remaining United Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Clinton Group sold 7,200 United Therapeutics shares in Q3 2018, an estimated $815K.
  • Clinton Group first reported a position in United Therapeutics in Q2 2013 and held it in 16 quarters.
  • Clinton Group's United Therapeutics position peaked at $6.65M in Q1 2016.
  • 367 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.